Innovation Committee received 231 applications for Innovation Funding in Germany

18

Nov 2022

On October 28, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) reported that 231 applications were received for innovation funding of healthcare research projects.

The applications received concerned the following topics:

  • Health in climate change: 26 applications;
  • Digitization and networking of quality-assured guideline knowledge and further development of the methodology: 15 applications;
  • Health services research to improve the situation of affected people in the provision of aids: 8 applications;
  • Improvement of specialist medical and dental care in inpatient care facilities: 10 applications;
  • Prerequisites for the development and requirements for the implementation of eHealth in patient care: 42 applications;
  • Health services research on aftercare and discharge management: 24 applications;
  • Drug Therapy: Impact of Switching from Best Supportive Care (BSC) or Off-Label Use (OLU) to Indication-Specific Drugs: 7 applications.

Also, 31 applications were received for the development or further development of the clinical guidelines:

  • Healthcare in more frequent diseases with a cross-sectoral need for coordination: 8 applications;
  • Provision of target groups with special needs (e.g., children, young people, older people and/or people in need of care, gender-specific characteristics, people with disabilities, ethical aspects): 14 applications;
  • Health of the population/public health (e.g., health promotion, prevention through lifestyle modification, protective measures, health communication): 3 applications;
  • Intensive care of critically ill patients: 6 applications.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

23

Mar 2023

In February 2023, the Scottish Health Technology Group, SHTG, released three MedTech-related assessments: selective internal radiation therapies (SIRT) for treating primary hepatocellular carcinoma, Feeling Good app, store-and-forward teledermatology for triage of primary care referrals.

Read more

21

Mar 2023

On March 8, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the coverage of the INTERVAPOR system for lung volume reduction under Forfait innovation program.

Read more

17

Mar 2023

On March 2, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for new forms of care. A total of six prioritized topics are defined. The preparation of a complete application can be supported for a period of up to six months with a grant of up to a maximum of €75,000. The deadline for submitting ideas is May 16, 2023.

Read more

16

Mar 2023

In January-February 2023, Health Technology Wales published sixteen Medtech-related Topic Exploration Reports (TER), including stereotactic radiosurgery, percutaneous implantation of pulmonary artery pressure sensors, ambulatory patch ECG devices, and others; however, Health Technology Wales will not proceed with full appraisals on these topics. No Guidance was released for Medtech in January-February 2023.

Read more

15

Mar 2023

In March 2023, a new ‘AI and Digital Regulations Service’ for developers and adopters of artificial intelligence (AI) and digital technologies was launched in England. Four organizations provide this multi-agency advisory service: NICE, Care Quality Commission, Medicines and Healthcare products Regulatory Agency, and Health Research Authority. The website is currently in public beta and focused on information for developers.

Read more